logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Leukemia And Lymphoma Detection Of Minimal Residual Disease Theodore F Zipf

  • SKU: BELL-22111486
Leukemia And Lymphoma Detection Of Minimal Residual Disease Theodore F Zipf
$ 31.00 $ 45.00 (-31%)

4.3

48 reviews

Leukemia And Lymphoma Detection Of Minimal Residual Disease Theodore F Zipf instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 3 MB
Author: Theodore F. Zipf, PhD, MD and Dennis A. Johnston, PhD
ISBN: 9780896039667, 0896039668
Language: English
Year: 2007

Product desciption

Leukemia And Lymphoma Detection Of Minimal Residual Disease Theodore F Zipf by Theodore F. Zipf, Phd, Md And Dennis A. Johnston, Phd 9780896039667, 0896039668 instant download after payment.

In Leukemia and Lymphoma: Detection of Minimal Residual Disease, hands-on experts describe and discuss the minimal residual disease (MRD) methods they have successfully pioneered for leukemias and lymphomas. They apply reverse transcription PCR (RT-PCR) to acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), and acute promyelocytic leukemia (APL). Other PCR methods are used for Non-Hodgkin's Lymphoma and for the monitoring of follicular lymphoma. Additional chapters address the use of real-time quantitative PCR (RQ-PCR), the emergent method of choice, in patients with acute lymphoblastic leukemia (ALL), the evaluation of MRD techniques in clinical trials, and the application of flow cytometry techniques.

Related Products